Cheol‐Jung Lee
- Co-authors
- Yong‐Yeon ChoHye Suk LeeJoo Young LeeHan Chang KangHyun‐Jung AnMee‐Hyun LeeDae Joon KimGa-Eun Lee
- Topics
- Ubiquitin and proteasome pathways (6 papers)Bioactive Compounds and Antitumor Agents (4 papers)PI3K/AKT/mTOR signaling in cancer (4 papers)
- Cited by
- ToxicologyPharmacologyRehabilitation
- Partner nations
- South KoreaUnited StatesUnited Kingdom
In The Last Decade
Cheol‐Jung Lee
34 papers receiving 451 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 286
- Oncology 101
- Immunology 81
- Cancer Research 50
- Pathology and Forensic Medicine 43
Countries citing papers authored by Cheol‐Jung Lee
This map shows the geographic impact of Cheol‐Jung Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheol‐Jung Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheol‐Jung Lee more than expected).
Fields of papers citing papers by Cheol‐Jung Lee
This network shows the impact of papers produced by Cheol‐Jung Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheol‐Jung Lee. The network helps show where Cheol‐Jung Lee may publish in the future.
Co-authorship network of co-authors of Cheol‐Jung Lee
This figure shows the co-authorship network connecting the top 25 collaborators of Cheol‐Jung Lee. A scholar is included among the top collaborators of Cheol‐Jung Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheol‐Jung Lee. Cheol‐Jung Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | 6 | |
| 7 | 3 | |
| 8 | 4 | |
| 9 | 2 | |
| 10 | 8 | |
| 11 | 9 | |
| 12 | 5 | |
| 13 | 3 | |
| 14 | 10 | |
| 15 | 3 | |
| 16 | 4 | |
| 17 | 7 | |
| 18 | 44 | |
| 19 | 61 | |
| 20 | 20 |
About Cheol‐Jung Lee
Cheol‐Jung Lee is a scholar working on Toxicology, Nephrology and Transplantation, having authored 35 papers that have together received 456 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Bioactive Compounds and Antitumor Agents (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Toxicology (18 citations), Pharmacology (41 citations) and Rehabilitation (29 citations). Cheol‐Jung Lee has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Yong‐Yeon Cho, Hye Suk Lee, Joo Young Lee, Han Chang Kang, Hyun‐Jung An, Mee‐Hyun Lee, Dae Joon Kim, Ga-Eun Lee, Juhee Park and Sei‐Ryang Oh. Their work appears in journals such as Proceedings of the National Academy of Sciences, Analytical Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.